Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-05-17 Sale | 2023-05-19 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 4,122 | $21.38 | $88,108 | 927,880 (Indirect Direct) | View |
| 2023-05-17 Sale | 2023-05-19 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks | 1,330 | $21.38 | $28,429 | 317,929 (Indirect Direct) | View |
| 2023-05-17 Sale | 2023-05-19 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 245 | $21.38 | $5,237 | 6,116 (Direct) | View |
| 2023-04-21 Sale | 2023-04-25 6:33 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 2,342 | $18.65 | $43,678 | 5,636 (Direct) | View |
| 2023-02-17 Sale | 2023-02-22 7:28 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks | 3,557 | $19.06 | $67,796 | 94,546 (Direct) | View |
| 2023-02-17 Sale | 2023-02-22 7:28 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 1,244 | $19.06 | $23,711 | 1,614 (Direct) | View |
| 2023-02-17 Sale | 2023-02-22 7:27 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 12,194 | $19.06 | $232,418 | 536,885 (Direct) | View |
| 2022-10-06 Purchase | 2022-10-11 4:31 pm | ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK See Remarks 10% Owner | 1,355,932 | $14.75 | $19,999,997 | 17,628,567 (Indirect) | View |
| 2022-03-30 Sale(A) | 2022-04-04 07:37 am | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks | 135,000 | $16.21 | $2,187,740 | 89,529 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-05-14 Exercise | 2023-05-16 8:04 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 7,979 | $0 | 987,858 (Direct) | View |
| 2023-05-14 Exercise | 2023-05-16 8:01 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 725 | $0 | 11,439 (Direct) | View |
| 2023-05-14 Exercise | 2023-05-16 7:57 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks | 3,989 | $0 | 347,241 (Direct) | View |
| 2023-04-18 Exercise | 2023-04-20 6:34 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 6,364 | $0 | 20,648 (Direct) | View |
| 2023-04-04 Option Award | 2023-04-12 7:00 pm | N/A 2033-04-04 | ROCKET PHARMACEUTICALS INC. | RCKT | White Mark Andrew Chief Medical Officer | 134,401 | $0 | 134,401 (Direct) | View |
| 2022-05-19 Other | 2023-04-05 4:31 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK See Remarks 10% Owner | 590,744 | $0 | 19,748,348 (Indirect) | View |
| 2023-02-14 Exercise(A) | 2023-02-22 7:25 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks | 8,574 | $0 | 281,550 (Direct) | View |
| 2023-02-14 Option Award(A) | 2023-02-22 7:25 pm | N/A 2033-02-13 | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks | 166,037 | $0 | 281,550 (Direct) | View |
| 2023-02-14 Exercise(A) | 2023-02-22 7:25 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks | 15,720 | $0 | 565,756 (Direct) | View |
| 2023-02-14 Option Award(A) | 2023-02-22 7:25 pm | N/A 2033-02-13 | ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks | 265,661 | $0 | 565,756 (Direct) | View |
| 2023-02-14 Exercise(A) | 2023-02-22 7:25 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 2,858 | $0 | 75,075 (Direct) | View |
| 2023-02-14 Option Award(A) | 2023-02-22 7:25 pm | N/A 2033-02-13 | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 66,414 | $0 | 75,075 (Direct) | View |
| 2023-02-14 Exercise(A) | 2023-02-22 7:25 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 31,440 | $0 | 1,484,059 (Direct) | View |
| 2023-02-14 Option Award(A) | 2023-02-22 7:25 pm | N/A 2033-02-13 | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 464,907 | $0 | 1,484,059 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-16 4:45 pm | N/A 2033-02-13 | ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel | 116,226 | $0 | 116,226 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-16 4:45 pm | N/A 2033-02-13 | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 66,414 | $0 | 66,414 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-16 4:45 pm | N/A 2033-02-13 | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks | 166,037 | $0 | 166,037 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-16 4:45 pm | N/A 2033-02-13 | ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks | 265,661 | $0 | 265,661 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-16 4:45 pm | N/A 2033-02-13 | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 464,907 | $0 | 464,907 (Direct) | View |
| 2022-12-23 Other | 2022-12-23 4:42 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK See Remarks 10% Owner | 1 | $0 | 1 (Indirect) | View |
| 2022-12-22 Other | 2022-12-22 6:33 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK See Remarks 10% Owner | 1 | $0 | 1 (Indirect) | View |
| 2022-08-12 Option Award | 2022-08-16 5:33 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks | 22,896 | $0 | 22,896 (Direct) | View |
| 2022-08-12 Option Award | 2022-08-16 5:31 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks | 52,489 | $0 | 52,489 (Direct) | View |
| 2022-08-12 Option Award | 2022-08-16 5:27 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 14,310 | $0 | 14,310 (Direct) | View |
| 2022-08-12 Option Award | 2022-08-16 5:24 pm | N/A 2032-08-11 | ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel | 49,081 | $0 | 49,081 (Direct) | View |
| 2022-06-13 Option Award | 2022-06-15 9:07 pm | N/A 2032-06-13 | ROCKET PHARMACEUTICALS INC. | RCKT | Malik Fady Ibraham Director | 47,745 | $0 | 47,745 (Direct) | View |
| 2022-06-13 Option Award | 2022-06-15 9:07 pm | N/A 2032-06-13 | ROCKET PHARMACEUTICALS INC. | RCKT | Makker Gotham Director | 5,876 | $6.8 | 53,621 (Direct) | View |
| 2022-06-13 Option Award | 2022-06-15 9:07 pm | N/A 2032-06-13 | ROCKET PHARMACEUTICALS INC. | RCKT | Makker Gotham Director | 47,745 | $0 | 53,621 (Direct) | View |
| 2022-06-13 Option Award | 2022-06-15 9:07 pm | N/A 2032-06-13 | ROCKET PHARMACEUTICALS INC. | RCKT | Yalamanchi Naveen Director | 47,745 | $0 | 47,745 (Direct) | View |
| 2022-06-13 Option Award | 2022-06-15 9:07 pm | N/A 2032-06-13 | ROCKET PHARMACEUTICALS INC. | RCKT | Bjork Elisabeth Director | 7,345 | $6.8 | 55,090 (Direct) | View |
| 2022-06-13 Option Award | 2022-06-15 9:07 pm | N/A 2032-06-13 | ROCKET PHARMACEUTICALS INC. | RCKT | Bjork Elisabeth Director | 47,745 | $0 | 55,090 (Direct) | View |
| 2022-06-13 Option Award | 2022-06-15 9:07 pm | N/A 2032-06-13 | ROCKET PHARMACEUTICALS INC. | RCKT | WONG RODERICK Director 10% Owner | 5,876 | $6.8 | 53,621 (Direct) | View |
| 2022-06-13 Option Award | 2022-06-15 9:07 pm | N/A 2032-06-13 | ROCKET PHARMACEUTICALS INC. | RCKT | WONG RODERICK Director 10% Owner | 47,745 | $0 | 53,621 (Direct) | View |
| 2022-06-13 Option Award | 2022-06-15 9:07 pm | N/A 2032-06-13 | ROCKET PHARMACEUTICALS INC. | RCKT | GRANADILLO PEDRO P Director | 10,283 | $6.8 | 58,028 (Direct) | View |
| 2022-06-13 Option Award | 2022-06-15 9:07 pm | N/A 2032-06-13 | ROCKET PHARMACEUTICALS INC. | RCKT | GRANADILLO PEDRO P Director | 47,745 | $0 | 58,028 (Direct) | View |
| 2022-06-13 Option Award | 2022-06-15 9:07 pm | N/A 2032-06-13 | ROCKET PHARMACEUTICALS INC. | RCKT | SOUTHWELL DAVID P Director | 47,745 | $0 | 47,745 (Direct) | View |
| 2022-06-13 Option Award | 2022-06-15 9:07 pm | N/A 2032-06-13 | ROCKET PHARMACEUTICALS INC. | RCKT | BOESS CARSTEN Director | 47,745 | $0 | 47,745 (Direct) | View |
| 2022-04-18 Option Award | 2022-04-20 4:06 pm | N/A 2032-04-17 | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 47,964 | $0 | 47,964 (Direct) | View |